Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Interferon regulatory factor 5 and autoimmune lupus.

Xu WD, Pan HF, Xu Y, Ye DQ.

Expert Rev Mol Med. 2013 Jul 24;15:e6. doi: 10.1017/erm.2013.7. Review.

PMID:
23883595
2.

IRF5-mediated signaling and implications for SLE.

Lazzari E, Jefferies CA.

Clin Immunol. 2014 Aug;153(2):343-52. doi: 10.1016/j.clim.2014.06.001. Epub 2014 Jun 10. Review.

PMID:
24928322
3.

Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice.

Tada Y, Kondo S, Aoki S, Koarada S, Inoue H, Suematsu R, Ohta A, Mak TW, Nagasawa K.

Arthritis Rheum. 2011 Mar;63(3):738-48. doi: 10.1002/art.30183.

4.
5.

Interferon regulatory factors in human lupus pathogenesis.

Salloum R, Niewold TB.

Transl Res. 2011 Jun;157(6):326-31. doi: 10.1016/j.trsl.2011.01.006. Epub 2011 Feb 8. Review.

6.

Association of signaling transducers and activators of transcription 1 and systemic lupus erythematosus.

Liang Y, Xu WD, Yang XK, Fang XY, Liu YY, Ni J, Qiu LJ, Hui P, Cen H, Leng RX, Pan HF, Ye DQ.

Autoimmunity. 2014 May;47(3):141-5. doi: 10.3109/08916934.2013.873415. Epub 2014 Jan 20. Review.

PMID:
24437638
7.

A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5.

Sigurdsson S, Nordmark G, Garnier S, Grundberg E, Kwan T, Nilsson O, Eloranta ML, Gunnarsson I, Svenungsson E, Sturfelt G, Bengtsson AA, Jönsen A, Truedsson L, Rantapää-Dahlqvist S, Eriksson C, Alm G, Göring HH, Pastinen T, Syvänen AC, Rönnblom L.

Hum Mol Genet. 2008 Sep 15;17(18):2868-76. doi: 10.1093/hmg/ddn184. Epub 2008 Jun 25.

8.

Contribution of IRF5 in B cells to the development of murine SLE-like disease through its transcriptional control of the IgG2a locus.

Savitsky DA, Yanai H, Tamura T, Taniguchi T, Honda K.

Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10154-9. doi: 10.1073/pnas.1005599107. Epub 2010 May 17.

9.

A redundant epistatic interaction between IRF5 and STAT4 of the type I interferon pathway in susceptibility to lupus and rheumatoid arthritis.

Kim K, Cho SK, Han TU, Kim JH, Kang SJ, Kang C, Bae SC.

Lupus. 2013 Nov;22(13):1336-40. doi: 10.1177/0961203313504479. Epub 2013 Sep 6.

PMID:
24014567
10.

A compass that points to lupus: genetic studies on type I interferon pathway.

Kyogoku C, Tsuchiya N.

Genes Immun. 2007 Sep;8(6):445-55. Epub 2007 Jun 21. Review.

PMID:
17581625
11.

Genetic variants and disease-associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosus.

Feng D, Stone RC, Eloranta ML, Sangster-Guity N, Nordmark G, Sigurdsson S, Wang C, Alm G, Syvänen AC, Rönnblom L, Barnes BJ.

Arthritis Rheum. 2010 Feb;62(2):562-73. doi: 10.1002/art.27223.

12.

Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus.

Sigurdsson S, Göring HH, Kristjansdottir G, Milani L, Nordmark G, Sandling JK, Eloranta ML, Feng D, Sangster-Guity N, Gunnarsson I, Svenungsson E, Sturfelt G, Jönsen A, Truedsson L, Barnes BJ, Alm G, Rönnblom L, Syvänen AC.

Hum Mol Genet. 2008 Mar 15;17(6):872-81. Epub 2007 Dec 6.

PMID:
18063667
13.

Cis-regulation of IRF5 expression is unable to fully account for systemic lupus erythematosus association: analysis of multiple experiments with lymphoblastoid cell lines.

Alonso-Perez E, Suarez-Gestal M, Calaza M, Kwan T, Majewski J, Gomez-Reino JJ, Gonzalez A.

Arthritis Res Ther. 2011 May 31;13(3):R80. doi: 10.1186/ar3343.

14.

Interferon regulatory factor 5 in the pathogenesis of systemic lupus erythematosus.

Cham CM, Ko K, Niewold TB.

Clin Dev Immunol. 2012;2012:780436. doi: 10.1155/2012/780436. Epub 2012 Nov 1. Review.

15.

Association of a common interferon regulatory factor 5 (IRF5) variant with increased risk of systemic lupus erythematosus (SLE).

Demirci FY, Manzi S, Ramsey-Goldman R, Minster RL, Kenney M, Shaw PS, Dunlop-Thomas CM, Kao AH, Rhew E, Bontempo F, Kammerer C, Kamboh MI.

Ann Hum Genet. 2007 May;71(Pt 3):308-11. Epub 2006 Dec 12.

16.

Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus.

Kozyrev SV, Lewén S, Reddy PM, Pons-Estel B; Argentine Collaborative Group, Witte T; German Collaborative Group, Junker P, Laustrup H, Gutiérrez C, Suárez A, Francisca González-Escribano M, Martín J; Spanish Collaborative Group, Alarcón-Riquelme ME.

Arthritis Rheum. 2007 Apr;56(4):1234-41.

17.

Monocytes from Irf5-/- mice have an intrinsic defect in their response to pristane-induced lupus.

Yang L, Feng D, Bi X, Stone RC, Barnes BJ.

J Immunol. 2012 Oct 1;189(7):3741-50. Epub 2012 Aug 29.

18.

Genome-wide profiling of target genes for the systemic lupus erythematosus-associated transcription factors IRF5 and STAT4.

Wang C, Sandling JK, Hagberg N, Berggren O, Sigurdsson S, Karlberg O, Rönnblom L, Eloranta ML, Syvänen AC.

Ann Rheum Dis. 2013 Jan;72(1):96-103. doi: 10.1136/annrheumdis-2012-201364. Epub 2012 Jun 23.

PMID:
22730365
19.

Exon 6 variants carried on systemic lupus erythematosus (SLE) risk haplotypes modulate IRF5 function.

Wen F, Ellingson SM, Kyogoku C, Peterson EJ, Gaffney PM.

Autoimmunity. 2011 Mar;44(2):82-9. doi: 10.3109/08916934.2010.491842. Epub 2010 Aug 9.

20.

A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus.

Graham RR, Kozyrev SV, Baechler EC, Reddy MV, Plenge RM, Bauer JW, Ortmann WA, Koeuth T, González Escribano MF; Argentine and Spanish Collaborative Groups, Pons-Estel B, Petri M, Daly M, Gregersen PK, Martín J, Altshuler D, Behrens TW, Alarcón-Riquelme ME.

Nat Genet. 2006 May;38(5):550-5. Epub 2006 Apr 16.

PMID:
16642019

Supplemental Content

Support Center